FDA Approves Drug For Treatment Of Advanced Breast Cancer
Reuters (12/16, Maddipatla) reports, “MacroGenics Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its drug Margenza in combination with chemotherapy for the treatment of an advanced type of breast cancer in patients who failed two or more prior therapies.” The company “said it was expecting to launch the drug in March.” Cancer […]